Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

DHT stops hair regrowth in mice, similar to human hair loss.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Testosterone reduces key molecules needed for early pregnancy in rats.

Some supplements and hormones can increase hair loss by raising DHT levels.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Androgens can both increase and decrease hair growth in different parts of the body.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Taking Propecia might lead to the development of cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.